publication venue for
- Dr Paul Janssen research award winner presentation: Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia 2007
- Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of Neuropsychopharmacology. 36:61-75. 2021
- Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders. 35:173-193. 2020
- Antipsychotic drug exposure and risk of fracture. 33:181-196. 2018
- Placebo response in trichotillomania. 32:350-355. 2017
- Quetiapine augmentation of serotonin reuptake inhibitors in treatment-refractory obsessive–compulsive disorder. 27:1-1. 2012
- Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial. 24:87-96. 2009
- Double-blind, placebo-controlled study of INN 00835 (netamiftide) in the treatment of outpatients with major depression.. 16:345-352. 2001
- Diagnosis and treatment of premenstrual dysphoric disorder: an update.. 15 Suppl 3:S5-17. 2000